QINGDAO BAHEAL MEDICAL INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.52 CNY | +3.14% |
|
-4.66% | -12.10% |
| Sales 2024 * | 8.61B 1.19B 99.01B | Sales 2025 * | 10.39B 1.43B 120B | Capitalization | 16.57B 2.29B 191B |
|---|---|---|---|---|---|
| Net income 2024 * | 862M 119M 9.92B | Net income 2025 * | 1.11B 153M 12.78B | EV / Sales 2024 * | 1.92 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.59 x |
| P/E ratio 2024 * |
19.2
x | P/E ratio 2025 * |
14.9
x | Employees | 2,642 |
| Yield 2024 * |
1.97% | Yield 2025 * |
2.27% | Free-Float | 20.1% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.14% | ||
| 1 week | -4.66% | ||
| Current month | -5.15% | ||
| 1 month | -4.95% | ||
| 3 months | -1.04% | ||
| 6 months | +1.68% | ||
| Current year | -12.10% |
1 week
28.68
35.00
1 month
28.6835.00
Current year
25.5637.60
1 year
21.4043.50
3 years
18.3856.16
5 years
18.3856.16
10 years
18.3856.16
| Managers | Title | Age | Since |
|---|---|---|---|
Hai Shen Chen
FOU | Founder | 62 | 08/05/08 |
Xiao Wei Zhu
FOU | Founder | 61 | 08/05/08 |
Gang Fu
CEO | Chief Executive Officer | 54 | 08/05/08 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ming Zhong Fu
BRD | Director/Board Member | 74 | 04/22/04 |
Xian Jing Hao
BRD | Director/Board Member | 59 | 04/22/04 |
Yin Di Lu
BRD | Director/Board Member | 62 | 04/22/04 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 31.52 | +3.14% | 3,641,695 |
| 25/24/25 | 30.56 | +1.73% | 3,709,094 |
| 24/24/24 | 30.04 | -1.02% | 6,627,190 |
| 23/24/23 | 30.35 | -10.89% | 10,121,990 |
| 22/24/22 | 34.06 | +3.02% | 2,232,649 |
End-of-day quote Shenzhen S.E., April 26, 2024
More quotes
Qingdao Baheal Medical Inc is a China-based company mainly providing comprehensive marketing services for pharmaceutical product manufacturers. The Company provides brand operation, wholesale distribution and retail services for pharmaceutical products. Its brand operation services include consumer education, product academic promotion, marketing planning, business contacts, product distribution, flow tracking and supply chain management services. The Company's wholesale distribution business mainly centers on Qingdao and Beijing, and radiates second-level and above hospitals, community clinics and pharmacies in surrounding cities. Its wholesale distribution products include medicines, Chinese herbal medicine pieces, medical equipment, diagnostic reagents, medical consumables, among others. The Company mainly conducts its business within domestic market.
Sector
Pharmaceuticals
Calendar
13/05/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
31.52
CNY
Average target price
51
CNY
Spread / Average Target
+61.80%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -12.10% | 2.29B | |
| +17.35% | 71.39B | |
| +2.39% | 25.1B | |
| +0.24% | 8.59B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -2.61% | 3.86B | |
| +22.08% | 3.64B |
- Stock Market
- Equities
- 301015 Stock
